Medical Surgical Operating Table (SX-2B)

Name: Medical Surgical Operating Table (SX-2B)
Brand: Taixing Suxing Co., Ltd.
SKU: 646332685

Jiangsu, ChinaTaixing Suxing Co., Ltd.

US$1,000.00

1-4 Pieces

US$900.00

5+ Pieces

Product profile

Customization

Available

Material

Stainless Steel

Type

Orthopedic Bed

Model NO.

SX-2B

Folded

Using Ambient

Hospital

Numbers of Function

Three-function

Certification

ISO13485

Condition

New

Medical Device Supervision Type

Medical Device Registration No

Su20131540106

Transport Package

wooden package

Specification

suxing

Trademark

suxing

Origin

Jiangsu

Production Capacity

10000 units/year

Company profile

Taixing Suxing Co., Ltd.

Jiangsu, China

CertifiedBusiness Type: Trading CompanyExport Year: 2012-10-01 CertifiedNearest Port: Shanghai PortAverage Response Time: ≤8.19h CertifiedTerms of Payment: LC, T/T, Western Union CertifiedInternational Commercial Terms(Incoterms): FOB, CIF, CFR, EXW

AI-Powered supplier vetting

SummaryTaixing Suxing Co., Ltd. is a trading company based in Jiangsu, China, established in 2010. They have extensive experience in selling X-ray related products, with a significant focus on product quality and after-sales service. Despite being a small company with only two employees, they operate five production lines and export a large portion of their products. The company holds ISO9001:2000 and CE certifications, indicating a commitment to quality standards. However, they have limited R&D experience and a small manufacturing plant area.

CertificationsThe company has passed ISO9001:2000 and CE quality system assessments, indicating compliance with international quality standards.

After-Sales capabilityThe company emphasizes after-sales service as a key part of their business, with services spread across various provinces in China.

R&D capabilityThe company has only one R&D engineer, indicating limited innovation capability.

Production capacityWith five production lines and an annual production output between US$10 million and US$50 million, the company has a moderate production capability.